CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 584 enrolled
Drug / intervention
Observationalother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04717492
NCT04717492N/ACompleted
CompareCT.gov

An Observational Study of Beta-Blocker Use in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Acute Myocardial Infarction

University of Minnesota·observational·Posted Jan 22, 2021·Updated Jan 31, 2025

In Brief

An observational study evaluating Observational for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 584 participants across 24 sites.

Detailed Summary

The study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and Chronic Obstructive Pulmonary Disease (COPD) to determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to characterize the phenotypic expression and severity of their underlying lung disease. Patients with will be identified via the EMR. 571 participants will be enrolled.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesUnited States
CollaboratorsUnited States Department of Defense, University of Alabama at Birmingham

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJan 22, 2021
Enrollment StartJun 28, 2020
Primary CompletionMay 18, 2022
Study CompletionDec 2, 2022
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 5.4 years ago

Interventions

Observationalother

Observational